PRODUCTION OF VARIOUS STRENGTH OF INJECTABLE LMP744 FOR CLINICAL USE; POP: 02/14/2020 - 02/13/2021
$512,500N02FY2020CANIH
Irisys, Inc., San Diego CA
Investigators
Abstract
The Contractor will manufacture injectable LMP744 at various strength under cGMP condition for clinical use including one base year and four (4) one-year options during the next five years.
View original record on NIH RePORTER →